In the latest session, Chimerix Inc (NASDAQ: CMRX) closed at $0.96 down -12.73% from its previous closing price of $1.10. In other words, the price has decreased by -$0.1400 from its previous closing price. On the day, 2728059 shares were traded.
Ratios:
For a deeper understanding of Chimerix Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.25 and its Current Ratio is at 10.25. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 23, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On September 07, 2022, CapitalOne started tracking the stock assigning a Overweight rating and target price of $7.
On April 29, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $20.Maxim Group initiated its Buy rating on April 29, 2021, with a $20 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 14 ’24 when Jakeman David sold 2,660 shares for $1.04 per share. The transaction valued at 2,777 led to the insider holds 141,232 shares of the business.
LaSpaluto Michelle sold 1,940 shares of CMRX for $2,023 on Feb 14 ’24. The CHIEF FINANCIAL OFFICER now owns 110,999 shares after completing the transaction at $1.04 per share. On Feb 14 ’24, another insider, Andriole Michael T., who serves as the PRESIDENT AND CEO of the company, sold 1,744 shares for $1.04 each. As a result, the insider received 1,809 and left with 447,021 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMRX now has a Market Capitalization of 98.13M and an Enterprise Value of -83.40M. For the stock, the TTM Price-to-Sale (P/S) ratio is 267.63 while its Price-to-Book (P/B) ratio in mrq is 0.44. Its current Enterprise Value per Revenue stands at -257.41 whereas that against EBITDA is 0.90.
Stock Price History:
Over the past 52 weeks, CMRX has reached a high of $1.57, while it has fallen to a 52-week low of $0.88. The 50-Day Moving Average of the stock is 1.0532, while the 200-Day Moving Average is calculated to be 1.0694.
Shares Statistics:
For the past three months, CMRX has traded an average of 421.36K shares per day and 287.56k over the past ten days. A total of 88.93M shares are outstanding, with a floating share count of 79.33M. Insiders hold about 11.08% of the company’s shares, while institutions hold 46.03% stake in the company. Shares short for CMRX as of Feb 29, 2024 were 1.27M with a Short Ratio of 3.03, compared to 1.26M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.43% and a Short% of Float of 1.50%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.22 for the current quarter, with a high estimate of -$0.17 and a low estimate of -$0.26, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.17 and low estimates of -$0.27.
Analysts are recommending an EPS of between -$0.7 and -$1.05 for the fiscal current year, implying an average EPS of -$0.85. EPS for the following year is -$0.96, with 7 analysts recommending between -$0.7 and -$1.15.
